This activity is intended for healthcare professionals practicing in the United States who care for patients at risk for cognitive decline.
Join us for a complimentary dinner and CME as our experts discuss the latest efficacy and safety data from clinical trials of newly approved and emerging therapies and new therapeutic combinations for small cell lung cancer (SCLC).
Fatty Liver
Speaker will begin at 6:00 PM, please arrive early to sign in and be seated. Thank you